Correlation Between Nunzia Pharmaceutical and 4Front Ventures

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nunzia Pharmaceutical and 4Front Ventures at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nunzia Pharmaceutical and 4Front Ventures into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nunzia Pharmaceutical and 4Front Ventures Corp, you can compare the effects of market volatilities on Nunzia Pharmaceutical and 4Front Ventures and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nunzia Pharmaceutical with a short position of 4Front Ventures. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nunzia Pharmaceutical and 4Front Ventures.

Diversification Opportunities for Nunzia Pharmaceutical and 4Front Ventures

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Nunzia and 4Front is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Nunzia Pharmaceutical and 4Front Ventures Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 4Front Ventures Corp and Nunzia Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nunzia Pharmaceutical are associated (or correlated) with 4Front Ventures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 4Front Ventures Corp has no effect on the direction of Nunzia Pharmaceutical i.e., Nunzia Pharmaceutical and 4Front Ventures go up and down completely randomly.

Pair Corralation between Nunzia Pharmaceutical and 4Front Ventures

If you would invest  1.14  in 4Front Ventures Corp on December 2, 2024 and sell it today you would earn a total of  1.16  from holding 4Front Ventures Corp or generate 101.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Nunzia Pharmaceutical  vs.  4Front Ventures Corp

 Performance 
       Timeline  
Nunzia Pharmaceutical 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Nunzia Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Nunzia Pharmaceutical is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
4Front Ventures Corp 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in 4Front Ventures Corp are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, 4Front Ventures reported solid returns over the last few months and may actually be approaching a breakup point.

Nunzia Pharmaceutical and 4Front Ventures Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nunzia Pharmaceutical and 4Front Ventures

The main advantage of trading using opposite Nunzia Pharmaceutical and 4Front Ventures positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nunzia Pharmaceutical position performs unexpectedly, 4Front Ventures can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 4Front Ventures will offset losses from the drop in 4Front Ventures' long position.
The idea behind Nunzia Pharmaceutical and 4Front Ventures Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Money Managers
Screen money managers from public funds and ETFs managed around the world